Halberd Co. (OTCMKTS:HALB) Short Interest Update

Halberd Co. (OTCMKTS:HALB) was the target of a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 15,500 shares, an increase of 933.3% from the July 15th total of 1,500 shares. Based on an average daily volume of 2,296,600 shares, the short-interest ratio is currently 0.0 days.

Halberd Stock Performance

OTCMKTS:HALB opened at $0.01 on Tuesday. The business has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.01. Halberd has a 12-month low of $0.00 and a 12-month high of $0.01.

About Halberd

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.